AstraZeneca suffers diabetes drug setback for COVID
British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating COVID patients at risk of severe complications.
- Next story The best OnePlus phones for 2021
- Previous story Mysterious blackout in Iran threatens to undermine nuclear talks
Explore more
- ‘One just got me’: Biden has run-in with cicada
Cicadas wreak havoc before President Joe Biden departed on his first trip... - Biden’s US ambitions depend on this key state
When I saw that CNN’s Jeff Zeleny was in Arizona covering the... - The Rise of Digital Wallets in Europe
A digital wallet, or e-wallet, is essentially a mobile-based or online application... - Try This Whole-Banana Bread Recipe for Brunch
Bake something that tastes notably better than almost any other banana bread... - Former Colorado Police Officers Face Charges in Arrest of Woman With Dementia
One former officer with the Loveland Police Department was charged with assault... - Research shows melanoma rates in Utah outpace that of the rest of the U.S.
A letter published today by Huntsman Cancer Institute (HCI) at the University... - Biden faces crunch moment in his presidency
- Tunisia orders lockdown amid ‘worst’ ever health crisis
Tunisia ordered a partial lockdown from Sunday for the week-long Eid al-Fitr... - Apple will launch new products on April 20
Siri may have just let slip when Apple is planning its next... - Malaysia records highest daily increase in Covid-19 cases
